Literature DB >> 15868848

Childhood urinary tract infection: a clinical analysis of 597 cases.

Chan-Yao Wu1, Pao-Chin Chiu, Kai-Sheng Hsieh, Ching-Lan Chiu, Chen-Hung Shih, Yee-Hsuan Chiou.   

Abstract

OBJECTIVES OF STUDY: To gain new insights into the epidemiology, genitourinary (GU) tract anomalies, etiologies, susceptibility of urinary pathogens to antibiotics in children with urinary tract infection (UTI) during the past decade in Taiwan.
MATERIALS AND METHODS: By reviewing medical charts for patients admitted to Kaohsiung Veterans General Hospital between January 1995 and December 2003, we identified and enrolled patients 14 years of age or less admitted due to UTI that was confirmed by positive urine culture.
RESULTS: A total of 597 patients made up our sample. Sixty-eight percent of patients were 1 year old or younger. Boys predominated infant cohort (68.1%). Twenty-seven point one percent of the patients were found in urinalysis to have 5 white blood cells or fewer per high power field and 17.6% had positive nitrite reaction. The pathogens were Escherichia coli, the most common (74.7%), followed by Proteus spp. (6.7%), and Klebsiella spp. (6.4%). E. coli was resistant to ampicillin in 82.0% of the cases, followed by sulfamethoxazole/trimethoprim (55.2%), gentamicin (24.9%), and cefazolin (24%). Resistance to ampicillin and sulfamethoxazole/trimethoprim tended to increase year by year. Forty point seven percent (164/408) of patients had GU tract anomalies, the most common being vesicoureteral reflux (VUR) (87/164, 53.0%). Thirty-three point two percent of the patients with acute pyelonephritis, confirmed by 99mTc dimercaptosuccinic acid (DMSA) renal scan, had VUR.
CONCLUSION: Our cohort was predominated by boys, especially in those less than a year old. E. coli, the most common pathogen, had a higher rate of resistance to ampicillin and sulfamethoxazole/ trimethoprim. The pathogens that cause UTI were found to be becoming increasingly resistant to the common antimicrobial agents used in this study. The most common GU tract anomaly was VUR, yet the incidence was lower than that of other reports. A positive DMSA renal scan finding was a good indicator for prediction the possibility of VUR in UTI patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15868848

Source DB:  PubMed          Journal:  Acta Paediatr Taiwan        ISSN: 1608-8115


  7 in total

1.  Antimicrobial susceptibility of pediatric uropathogens in Thrace, Greece.

Authors:  Elpis Mantadakis; Aggelos Tsalkidis; Maria Panopoulou; Spyridon Pagkalis; Gregory Tripsianis; Mathew E Falagas; Mathew Falagas; Sophia Kartali-Ktenidou; Athanassios Chatzimichael
Journal:  Int Urol Nephrol       Date:  2010-06-04       Impact factor: 2.370

Review 2.  Vesicoureteral reflux and reflux nephropathy.

Authors:  Tej K Mattoo
Journal:  Adv Chronic Kidney Dis       Date:  2011-09       Impact factor: 3.620

3.  Antibiotic sensitivity and resistance in children with urinary tract infection in Sanliurfa.

Authors:  Mahmut Abuhandan; Bülent Güzel; Yeşim Oymak; Halil Çiftçi
Journal:  Turk J Urol       Date:  2013-06

4.  Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide.

Authors:  Nuno Cerca; Tomás Maira-Litrán; Kimberly K Jefferson; Martha Grout; Donald A Goldmann; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-19       Impact factor: 11.205

Review 5.  Dimercaptosuccinic acid scan or ultrasound in screening for vesicoureteral reflux among children with urinary tract infections.

Authors:  Nader Shaikh; Russell B Spingarn; Stephanie W Hum
Journal:  Cochrane Database Syst Rev       Date:  2016-07-05

6.  Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis.

Authors:  H Malekinejad; A Nikibakhsh; S Gholizadeh-Soltani; A Farshid
Journal:  Indian J Nephrol       Date:  2012-01

7.  Clinical features of acute focal bacterial nephritis in adults.

Authors:  Sumin Jiao; Zhe Yan; Congqin Zhang; Juan Li; Jiaomei Zhu
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.